Vyome Holdings (HIND) Change in Account Payables (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Change in Account Payables of -$25216.0 for Q1 2026, down 324.92% year-over-year from $11211.0 in Q1 2025, and down 226.45% quarter-over-quarter from $19941.0 in Q4 2025.
Vyome Holdings (HIND) Change in Account Payables (2015 - 2026) Analysis & Trends
Vyome Holdings' Change in Account Payables history runs 9 years deep, the most recent figure standing at -$25216.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 324.92% year-over-year to -$25216.0; the TTM figure through Mar 2026 stood at $37451.0 (up 219.75% YoY), while the FY2025 annual figure was $75216.0, down 21.63% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$25216.0, down from $19941.0 in the prior quarter.
- The five-year high for Change in Account Payables was $31515.0 in Q4 2024, with the low at -$25216.0 in Q1 2026.
- The 3-year median for Change in Account Payables is $15576.0 (2025), against an average of $9362.8.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables sank 36.73% in 2025, then slumped 324.92% in 2026.
- Vyome Holdings' Change in Account Payables stood at $31515.0 in 2024, then plunged by 36.73% to $19941.0 in 2025, then slumped by 226.45% to -$25216.0 in 2026.
- Business Quant data shows HIND's Change in Account Payables at -$25216.0 in Q1 2026, $19941.0 in Q4 2025, and $11211.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | -8.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.00 |
| Jun 30, 2026 | -8.00 |
| Mar 31, 2026 | -25,216.00 |
| Mar 31, 2026 | -25,216.00 |
| Dec 31, 2025 | 19,941.00 |
| Dec 31, 2025 | 19,941.00 |
| Mar 31, 2025 | 11,211.00 |
| Mar 31, 2025 | 11,211.00 |
| Dec 31, 2024 | 31,515.00 |
| Dec 31, 2024 | 31,515.00 |
| Mar 31, 2021 | -33,000.00 |
| Mar 31, 2021 | -33,000.00 |
| Dec 31, 2020 | -41,000.00 |
| Dec 31, 2020 | -41,000.00 |
| Sep 30, 2020 | -397,000.00 |
| Sep 30, 2020 | -397,000.00 |
| Jun 30, 2020 | -17,000.00 |
| Jun 30, 2020 | -17,000.00 |
| Mar 31, 2020 | 422,000.00 |
| Mar 31, 2020 | 422,000.00 |